NCT00393497View on ClinicalTrials.gov

A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2011

Conditions
Breast CancerLymphedema
Interventions
DRUG

bevacizumab

Bevacizumab 15 mg/kg IV every 21 days

Trial Locations (1)

46202

Indiana University Cancer Center, Indianapolis

All Listed Sponsors
lead

Indiana University School of Medicine

OTHER

NCT00393497 - A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment | Biotech Hunter | Biotech Hunter